AffiGEN® TransfectTM DNA In Vivo 3000
AffiGEN® TransfectTM DNA In Vivo 3000 represents a groundbreaking development in the field of DNA delivery. This remarkable innovation consists of a 28-amino-acid cationic peptide that was serendipitously discovered as a potent vector for in vivo DNA delivery.
Leveraging advanced protein alignment and simulation software, we meticulously synthesized, refined, screened, and validated this peptide by emulating the characteristics of virus proteins. To ensure optimal performance within the in vivo environment, we ingeniously integrated a shield peptide into the backbone, thereby minimizing potential interferences and achieving exceptional in vivo transfection efficiency.
AffiGEN® TransfectTM DNA In Vivo 3000 has been unequivocally demonstrated to yield the highest renilla luciferase expression in critical organs such as the lung, liver, spleen, and kidney.
Storage Recommendations:
For optimal results and stability, it is recommended to store AffiGEN® TransfectTM DNA In Vivo 3000 at a temperature of 4°C.
When stored under these conditions, this product maintains its integrity for a period exceeding 12 months.
In Vivo Transfection Reagents:
| Product | AffiGEN® TransfectTM DNA In Vivo 2000 Plus | AffiGEN® TransfectTM DNA In Vivo 3000 |
| Technology | Formulation from In Vitro transfection reagent | Novel cationic peptide |
| Length | Not specified | 28 amino-acids |
| Optimization | Refined, screened and validated |
Protein alignment and simulation software |
| Efficiency | High |
High, best renilla luciferase expression in lung, liver, spleen and kidney |
| Shield peptide | Yes | Yes |